Marketwired VIVALIS AND KITASATO SIGN A RESEARCH LICENSE TO EVALUATE EB66(R) CELL LINE FOR HUMAN VIRAL VACCINE PRODUCTION
companynewsgroup Home Page      
Return to Release | Remove Frame